These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 32718086)

  • 1. Interleukin-6 in Rheumatoid Arthritis.
    Pandolfi F; Franza L; Carusi V; Altamura S; Andriollo G; Nucera E
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting interleukin-6 in rheumatoid arthritis.
    Choy E
    Curr Rheumatol Rep; 2008 Oct; 10(5):413-7. PubMed ID: 18817647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.
    Raimondo MG; Biggioggero M; Crotti C; Becciolini A; Favalli EG
    Drug Des Devel Ther; 2017; 11():1593-1603. PubMed ID: 28579757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future.
    Kim GW; Lee NR; Pi RH; Lim YS; Lee YM; Lee JM; Jeong HS; Chung SH
    Arch Pharm Res; 2015; 38(5):575-84. PubMed ID: 25648633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date.
    Lazzerini PE; Capecchi PL; Guidelli GM; Selvi E; Acampa M; Laghi-Pasini F
    Drug Des Devel Ther; 2016; 10():3083-3098. PubMed ID: 27713619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?
    Avci AB; Feist E; Burmester GR
    BioDrugs; 2018 Dec; 32(6):531-546. PubMed ID: 30488231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6: from identification of the cytokine to development of targeted treatments.
    Assier E; Boissier MC; Dayer JM
    Joint Bone Spine; 2010 Dec; 77(6):532-6. PubMed ID: 20869898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Interleukin-6 Signaling in Clinic.
    Kang S; Tanaka T; Narazaki M; Kishimoto T
    Immunity; 2019 Apr; 50(4):1007-1023. PubMed ID: 30995492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6: designing specific therapeutics for a complex cytokine.
    Garbers C; Heink S; Korn T; Rose-John S
    Nat Rev Drug Discov; 2018 Jun; 17(6):395-412. PubMed ID: 29725131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An emerging role of interleukin-23 in rheumatoid arthritis.
    Yuan N; Yu G; Liu D; Wang X; Zhao L
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):185-191. PubMed ID: 31072166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targets for rheumatoid arthritis: Progress and promises.
    Alghasham A; Rasheed Z
    Autoimmunity; 2014 Mar; 47(2):77-94. PubMed ID: 24437572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin-6 therapy in rheumatoid arthritis.
    Woodrick R; Ruderman EM
    Bull NYU Hosp Jt Dis; 2010; 68(3):211-7. PubMed ID: 20969554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of blocking IL-6 outside of rheumatoid arthritis: current perspective.
    Murakami M; Nishimoto N
    Curr Opin Rheumatol; 2011 May; 23(3):273-7. PubMed ID: 21427577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with inhibition of interleukin-6.
    Choy E
    Rheum Dis Clin North Am; 2004 May; 30(2):405-15, viii. PubMed ID: 15172049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of interleukin-6 in rheumatoid arthritis].
    Manfredi M; Benucci M
    Recenti Prog Med; 2008 Jun; 99(6):291-4. PubMed ID: 18710059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 in the pathogenesis of rheumatoid arthritis.
    Park JY; Pillinger MH
    Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S4-10. PubMed ID: 17708744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 in rheumatoid arthritis.
    Nishimoto N
    Curr Opin Rheumatol; 2006 May; 18(3):277-81. PubMed ID: 16582692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blockade of IL-6 signaling in rational drug design.
    Adachi Y; Yoshio-Hoshino N; Nishimoto N
    Curr Pharm Des; 2008; 14(12):1217-24. PubMed ID: 18473869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis.
    Mircic M; Kavanaugh A
    Exp Cell Res; 2011 May; 317(9):1286-92. PubMed ID: 21439276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions of interleukin-34 and its emerging association with rheumatoid arthritis.
    Zhou RP; Wu XS; Xie YY; Dai BB; Hu W; Ge JF; Chen FH
    Immunology; 2016 Dec; 149(4):362-373. PubMed ID: 27550090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.